Tag Archive for: Grant Funding

How Grant Advance Funding Keeps Projects on Track When Payments Lag

/in /by

The “paid in arrears” model used by most government innovation grants creates a systemic working capital trap. Founders must bankroll 100% of project costs upfront, often for months, before they can claim a penny back. This reimbursement delay frequently spans two fiscal quarters, forcing a high-stakes choice: stall the technical roadmap or drain the company’s core cash reserves.

The strategic answer is to decouple your execution from the government’s administrative timeline. Grant advance funding fixes this friction by turning those pending milestones into immediate liquidity. Your technical targets should govern your project velocity, not the processing speed of a government office.

At SPRK Capital, we provide the specialist financial architecture that traditional high-street banks often overlook. As a dedicated UK finance partner for innovators, we understand that your R&D spend and grant awards are bankable assets. We bridge the gap between technical achievement and cash flow, ensuring that British scale-ups can deploy their capital precisely when their roadmap demands it.

Why do grant payment lags cause project “stuttering”?

Innovation grants rarely provide a smooth flow of capital. Instead, they create a “stutter” in execution. Because most schemes require granular evidence of spend through quarterly claims, you inevitably hit a three-to-five-month liquidity hole. During this window, management teams often “meter” their progress. They pause hardware orders or push back trial dates to keep the lights on until the next reimbursement arrives.

Stopping and restarting a project creates “technical debt” because you might lose your slot in a specialist lab or must recalibrate complex hardware cycles. Frequently, the cost of this lost momentum far exceeds the price of financing the gap. A Grant Advance facility keeps the project in constant motion. Implementing grant advance funding maintains the “Day 1” velocity you promised to your board and stakeholders, ensuring that your broader business expansion stays on schedule.

Can grant delays trigger talent attrition in R&D teams?

Top-tier engineers and researchers have options, and they join a scale-up to build things, not to sit idle. When payment lags squeeze your budget, the culture of momentum is the first thing to break. Specialists often interpret procurement freezes or hiring pauses as a sign of financial instability. This leads to “passive looking” and, eventually, the loss of key staff.

Bridging the payment gap is a vital retention strategy. By securing grant advance funding, you ensure your technical leads have the materials they need to keep their sprint cycles moving without interruption. Protecting this human capital prevents the catastrophic loss of institutional knowledge that happens when a developer exits mid-project because they don’t trust a government-tethered payroll.

How does Grant Advance Funding protect your “Preferred Customer” status?

Founders often damage their supply chain by treating subcontractors as an interest-free credit facility while waiting for a grant drawdown. While hardware suppliers usually demand payment within 30 days, a government reimbursement can take four times as long. Forcing partners to absorb that delay destroys professional trust. Subcontractors will eventually de-prioritise your project in favour of clients who pay on time.

Accessing your grant capital early lets you settle invoices on day one. You secure your reputation as a “preferred customer,” which is a major advantage in a market where lab space and specialist components are constantly backlogged. Prompt payment ensures you receive priority access. This reliability builds a resilient supply chain that stays with you into your commercial phase, a key component of showing investors you are a safe bet.

What are the “invisible costs” of a slipping R&D timeline?

The cost of capital is negligible compared to the cost of a missed market window. Slipping by just three months represents an entire quarter of lost competitive advantage. If a rival reaches the patent office first, your valuation takes the hit. Furthermore, missing a milestone can trigger a “technical query” from your Monitoring Officer (MO). These queries can freeze future tranches and bury your team in administrative red tape.

Utilising grant advance funding acts as a buffer against these risks. It gives you the autonomy to double down on a breakthrough or pivot based on new data without waiting for a quarterly review. You get to run your project like a commercial enterprise, rather than a rigid, grant-funded pilot.

Look at the daily burn rate of your technical team against your expected reimbursement date. If a 60-day delay forces that team to operate at half capacity, you are effectively throwing away expensive salary. Use our Cost Comparison Tool to see how a liquidity facility preserves the actual value of your grant award and prevents your R&D tax credits from becoming a paper illusion.

Secure Your Project Delivery Timeline

The gap between hitting a milestone and seeing the cash is a vulnerability that derails roadmaps. Innovation is a race. The winners are the ones who decouple their execution from external administrative friction.

Protect your momentum. Consult our finance specialists to discuss how advancing your grant funding can insulate your technical roadmap from payment lags. We can help you secure a facility tailored to your specific work packages, so your next milestone is funded before you even submit the claim.

Is the Surge in Applications Reshaping Access to R&D Grants?

/in , /by

The record-breaking volume of R&D Grants applications has turned a standard technical assessment into a high-stakes competition for a fixed pool of government capital. This saturation forces grant bodies like Innovate UK to apply aggressive filtration. Their focus has moved decisively toward financial resilience and “Best in Class” commercial viability. In this environment, technical excellence is no longer a guarantee of funding; your success hinges on proving the business can survive the “paid in arrears” cycle without stalling project delivery.

At SPRK, we build the financial architecture needed to navigate this heightened scrutiny. By advancing the value of your grant award or R&D tax credits, we turn a future government promise into immediate, deployable liquidity. This strategic buffer de-risks your project for assessors by proving your technical roadmap is insulated from the administrative bottlenecks and delays currently slowing down the UK funding landscape. A “funded” delivery plan is now a critical differentiator, so we invite you to speak with our advisors about how upfront liquidity can tilt the odds of a successful application in your favour.

Why was the Innovate UK Smart Grant scheme paused?

The landscape shifted in early 2025 when Innovate UK officially paused its flagship Smart Grant scheme. This decision followed a period where success rates hit a historic low of just 2.8%. The suspension was a direct response to an influx of thousands of applications many of which were low-quality, AI-generated submissions that clogged the system.

This pause marks a move toward a “tailored support” model that demands exhaustive commercial evidence. Applicants now face a system designed to filter out any business unable to demonstrate a robust “Line of Sight” to market. Financial stability is no longer a supporting factor; it is a mandatory hurdle for entry.

Why is the “Success Bar” for R&D Grants moving?

The sheer volume of applications allows grant bodies to be increasingly selective. Today’s market prioritises “Best in Class” status over simple technical merit. Assessors want proof that your project represents the most commercially viable option among hundreds of similar technologies. This reality forces founders to invest significantly more time in technical “Work Packages” and intellectual property (IP) defensibility before they even submit a first draft.

Increased competition also triggers a “Shadow Delay” in the assessment phase. With more files on their desks, Project Officers (POs) naturally take longer to review initial submissions. This administrative bottleneck creates a long “quiet period” between application and award, placing immense pressure on your existing cash runway while you wait for a decision.

Does your financial forecasting survive increased R&D grant scrutiny?

Following the 2025 Budget, the government pivoted toward a “Mission-Led” R&D strategy focusing on eight priority sectors, including Clean Energy and Life Sciences. Grant bodies now audit your solvency and alignment with these national growth targets as closely as your technology.

Assessors use this surge in applications to eliminate projects lacking robust financial forecasting. They look for evidence that you can fund the “arrears” portion of the project independently. If your balance sheet looks thin or your burn rate ignores the standard five-month reimbursement delay, technical merit alone will not save the application.

Securing a Grant Advance facility during the application stage demonstrates financial maturity. It proves to grant bodies that you possess the liquidity to maintain project momentum even if government payments stall. This level of planning separates bankable innovation leaders from risky scale-ups.

How does increased competition impact grant award timelines?

The competitive surge has a “domino effect” on the post-award process. As departments become overwhelmed, the time between receiving a “Conditional Offer Letter” and your first drawdown frequently stretches. Founders often find themselves in an administrative limbo: they hold a technical win but cannot access the funds because the Monitoring Officer (MO) is backlogged with competing projects.

This creates a dangerous “Valley of Death” where you have promised capital but no means to deploy it. Advancing your grant decouples your procurement and development from these external administrative hurdles. You execute your roadmap based on project needs rather than the processing speed of a government department.

Treat your grant application like a Series A pitch. In a crowded market, your financial delivery plan must be as innovative as your technology. Use our Cost Comparison Tool to model how advancing your award capital today protects your equity from a future emergency raise caused by grant delays.

What is the new reality of technical validation for R&D grants?

In a low-competition environment, a theoretical breakthrough might have been enough. Today, you must provide a clear “Line of Sight” to commercialisation. Grant bodies prioritise projects offering the highest “Return on Innovation” for the UK economy. Delivery planning must be granular, identifying specific subcontractors, material lead times, and risk-mitigation strategies.

For founders utilising R&D Tax Credits, this scrutiny extends to cost segregation. Any ambiguity in distinguishing grant-funded labour from R&D tax-eligible spend triggers an audit delay. A human expert advisor helps align these two funding streams so they complement your liquidity without causing a compliance conflict.

Secure Your Competitive Edge

The surge in R&D Grants applications represents a permanent shift in the UK innovation landscape. The rewards remain available, but the cost of entry is a higher standard of financial and technical preparedness.

Evaluate your project’s funding health. Consult our finance specialists to unlock the capital sitting in your awarded grant and ensure your innovation never hits a standstill. We invite you to discuss your specific roadmap with our team to ensure your next application carries the financial weight required to succeed.

How Can SMEs Use Grant Advance Funding to Overcome Gaps Between Grant Award and Project Start?

How Can SMEs Use Grant Advance Funding to Overcome Gaps Between Grant Award and Project Start?

/in /by

If you have secured an Innovate UK or similar innovation grant, you already understand one thing: the award letter does not fund next month’s payroll. Salaries fall due on fixed dates. Supplier deposits have payment terms. Delivery milestones do not move to match reimbursement timing. The funding gap between grant award and project start emerges at that point. Manage it early and mobilisation proceeds; leave it late and you compress runway.

Many Innovate UK and similar UK innovation grants operate on an arrears basis, with claims submitted for eligible costs incurred and paid. You incur eligible costs, compile evidence, submit the claim and the grant body reimburses you after review. You spend first and claim later. That structure does not change once the award is signed.

What Is a Funding Gap Between Grant Award and Project Start?

It is the period where you fund salaries, suppliers and project costs before the grant body releases the first milestone payment. Grant bodies release funds only after they validate evidence. When payroll runs monthly and reimbursement runs on review cycles, cash pressure appears quickly.

At the mobilisation stage, you need to know your exposure and your cash timeline. This is where structured Grant Advance Funding becomes practical. At SPRK, we structure funding against confirmed innovation awards so clients can mobilise before reimbursement lands.

Why Is There a Funding Gap Between Grant Award and Project Start?

Documentation quality, eligibility checks and administrative capacity inside the grant body determine payment timing. Even with a defined milestone schedule, reviewers extend the cycle when evidence requires clarification. Monitoring calls and follow-up questions can add further delay.

In practice, friction often comes from small breakdowns in evidence preparation. A supplier invoice coded incorrectly. Labour time not mapped cleanly to eligible activities. Cost categories that do not align precisely with the award letter. Each issue can shift reimbursement by weeks.

The sequence remains consistent:

  • Agreement execution and confirmation of delivery dates
  • Recruitment of specialist staff and engagement of contractors
  • Placement of orders linked to milestone delivery
  • Submission of evidence followed by review and validation

During that review window, burn rate continues. If reserves are tight, you slow recruitment or renegotiate supplier terms. Board conversations shift from growth to cash preservation.

What Costs Do SMEs Face Before the First Grant Payment Is Received?

Mobilisation compresses cash quickly. Early-stage expenditure typically includes:

  • Specialist engineering salaries
  • Contractor retainers secured upfront
  • Equipment deposits and hardware procurement
  • Software licences and cloud infrastructure
  • Insurance, audit and compliance costs

Illustrative example: take a £300,000 grant with a 40 per cent funding rate (funding rates vary by competition and organisation size). If the first milestone requires £120,000 of eligible spend, you commit close to £80,000 before reimbursement. Two senior engineers at £5,000 to £6,000 per month each, plus employer costs, can exceed £15,000 monthly before contractor fees and overhead allocation. That exposure accumulates before the first claim passes review.

Delaying hires protects short-term liquidity but pushes delivery outward and risks moving milestones beyond their original forecast. In time-critical projects, delay can cost more than structured finance.

To manage that exposure, SPRK structures advance funding against confirmed grant awards so businesses can hire and commit to suppliers on schedule without altering ownership.

How Does Grant Advance Funding Work for Innovate UK Projects?

How does Grant Advance Funding work? You draw a portion of your confirmed grant before the grant body reimburses expenditure.

For Innovate UK projects, SPRK reviews your signed agreement, milestone structure and eligible cost profile. We focus on timing and delivery credibility, not the headline award amount. We assess whether cost categories align with the award and whether forecasts reflect realistic reimbursement timing.

In practice:

  1. You provide award documentation, cost breakdown and milestone schedule.
  2. We size the advance against upcoming expenditure using conservative projections.
  3. When the grant body releases the milestone payment, you repay the advance from those funds.

We assess runway, historic performance and delivery credibility. Clear reporting and precise cost mapping support faster decisions.

This moves you from waiting on reimbursement to funding delivery upfront, allowing you to maintain planned hiring and milestone schedules.

The advance must reflect realistic milestone timing. If your forecast assumes every claim clears at first submission, you introduce risk into the structure. First-time grant recipients can underestimate review lag in their initial cash model.

For more detail on how this structure works in practice, see our Innovation Grant Loans page. If you are participating in collaborative or sector-specific competitions, you can also review our guidance on Open Innovation Grant Programmes.

Can SMEs Combine Grant Advance Funding with Other Non-Dilutive Funding?

A single facility rarely addresses every liquidity pressure. Mobilisation, annual tax credit timing and scaling demands often overlap.

Using Advance Funding for Milestone Liquidity

Grant Advance Funding bridges defined milestone-related cash gaps and keeps delivery aligned with agreed timelines.

When an R&D Tax Credit Loan Adds Stability

An R&D tax credit loan accelerates access to expected HMRC refunds within the financial year. You do not wait until year-end submission and processing. That acceleration stabilises runway when grant reimbursement and tax credit timing intersect, giving clearer visibility over cash position.

Used alongside advance funding, it reduces dependence on overdrafts and avoids equity discussions driven purely by short-term timing gaps.

Learn more about how R&D Tax Credit Loans can support annual liquidity cycles.

When an Innovation Term Loan Extends Runway

Where delivery spans multiple milestones or hiring accelerates, an innovation term loan extends working capital across a longer horizon. Structured repayment allows clearer planning around recruitment and supplier commitments.

A disciplined funding structure may combine:

  • Grant Advance Funding for mobilisation
  • An R&D tax credit loan for annual claim acceleration
  • An innovation term loan for extended runway stability

Each facility covers a different timing exposure.

Explore how Innovation Term Loans support scaling innovation-led businesses.

How Should SMEs Plan Cash Flow Around Innovate UK Grant Reimbursement Timelines?

Funding tools help, but cash modelling determines whether they work.

When you deliver an Innovate UK-funded project, build your forecast around evidence review cycles, monitoring calls and possible clarification delays. Assume friction and model conservatively.

Focus on:

  • Conservative milestone reimbursement assumptions
  • Weekly net cash tracking during mobilisation
  • Stress testing 60 to 90-day reimbursement delays
  • Hiring decisions tied to confirmed funding visibility
  • Supplier contracts structured around realistic drawdown timing

Advance funding should sit inside that model. You need visibility over funding envelope, repayment dates and burn rate.

Many projects do not fail because funding is unavailable. They stall because timing was misjudged.

What Are the Grant Advance Funding Eligibility Criteria for SMEs?

Grant Advance Funding eligibility criteria typically include:

  • A confirmed award and executed agreement
  • Defined milestone structure
  • Clearly identified eligible costs
  • Sufficient visibility over delivery timelines

Conditional awards, incomplete documentation or unclear cost allocation weaken the case for advance funding. Lenders look for discipline and transparency.

You remain accountable for delivery and compliance. Advance funding supports execution; it does not transfer responsibility.

Why Does Closing the Funding Gap Early Strengthen Project Delivery?

Closing the funding gap stabilises mobilisation. You recruit when required, commit to suppliers with confidence and complete milestones on schedule.

When runway feels controlled, boards focus on delivery rather than short-term cash pressure.

SPRK works with UK innovation-led SMEs to structure non-dilutive funding aligned with delivery milestones, tax credit timing and growth plans. Combined with complementary tools such as an R&D tax credit loan or innovation term loan, Grant Advance Funding helps spread timing risk and maintain delivery momentum.

From Grant Award to Funded Mobilisation

An innovation grant confirms your project has funding approval for delivery. It does not remove timing risk.

The gap between award and reimbursement is structural. Anticipate it, model it and structure funding around it to protect delivery.

If mobilisation begins within the next 30 to 60 days, review milestone timing, cash runway and funding structure now. Early structuring generally provides more control than reactive financing under pressure.

If you have a confirmed grant award and a defined project start date, speak to SPRK before your first major cost lands. A short review of your milestone schedule, cash runway and funding options will clarify whether Grant Advance Funding, an R&D tax credit loan or a wider innovation term facility is appropriate. You can contact our team to discuss your project structure and timelines in confidence.

 

Grant Advance Funding: A Smart Way to Start R&D Projects Before Grant Payments Arrive

Grant Advance Funding: A Smart Way to Start R&D Projects Before Grant Payments Arrive

/in /by

If your business has secured an innovation grant, the expectation is clear: work must start. Teams must hire staff and engage suppliers so R&D activity can begin. The challenge is that grant payments often do not arrive at the same time those costs begin.

This timing gap creates immediate pressure for UK businesses. Grant bodies approve projects and confirm funding, but reimbursement follows later through milestone claims or reporting cycles. That delay can slow delivery at the point momentum matters most.

Closing that gap starts with understanding how grant advance solutions work within the UK innovation grant system and how advance funding keeps projects moving once approval is in place.

Why do grant payments often fail to align with when R&D costs begin?

Grant payments arrive later because many UK innovation grants operate on a reimbursement or milestone-based structure. The grant body confirms eligibility and approves funding, then releases payments after reviewing evidence of spend, progress reports, or formal claims.

Grant bodies design this structure deliberately. Grant bodies must validate outcomes and ensure public money supports eligible activity while maintaining accountability. However, for the business delivering the project, this creates a predictable timing challenge.

R&D costs often begin immediately after approval:

  • Engineers and technical staff need to start work
  • Specialist suppliers require deposits
  • Equipment or software licences must be secured
  • Project timelines may link to commercial deadlines

By contrast, grant payments often arrive weeks or months later after teams submit and reviewers assess reports. The gap is structural, not a sign of delay or inefficiency.

Spotting this early helps founders and finance leads plan funding before delivery pressure forces reactive decisions.

What cash-flow pressures arise during grant-funded R&D?

When grant payments arrive after businesses incur R&D costs, leaders face immediate decisions that affect delivery quality and speed.

Common pressures include:

  • Delaying permanent hires and relying on short-term contractors
  • Phasing work more slowly than the project plan intended
  • Using internal cash reserves meant for other operational needs
  • Diverting senior time into short-term funding fixes

These pressures do not reflect weak financial management. They stem from a mismatch between innovation timelines and payment structures, which forces businesses to make delivery decisions earlier than funding arrives. If leaders leave these pressures unaddressed, they can extend project delivery, increase execution risk, or reduce the scope of R&D activity.

Advance funding exists for this moment, when delivery needs to move faster than grant payments allow.

What is grant advance funding?

Grant advance funding allows businesses to access capital against an awarded UK innovation grant before the grant body releases funds. See how grant advance funding works in practice for innovation-led UK businesses. It is a form of structured funding, not equity investment, designed to bridge timing gaps rather than replace long-term finance.

Rather than wait for reimbursement, the business receives an advance that covers project spend while grant payments remain pending. Once the grant funds arrive, they repay the advance.

At a structural level:

  • The funding aligns to an existing grant award
  • It does not require equity dilution

Repayment links to expected grant receipts, which limits exposure once the grant is paid.

This distinction separates grant advance funding from general business loans. It exists to support delivery timing, not long-term borrowing or balance sheet restructuring.

When should a business consider advance funding?

Advance funding becomes relevant when leaders need to decide how to cover a timing gap between project costs and grant payments. In most cases, the decision centres on if delivery can wait for reimbursement or needs funding in place earlier.

Common situations include:

  • The project must start immediately to meet commercial or technical deadlines
  • R&D costs concentrate early in the project lifecycle
  • Internal cash reserves need protection for core operations
  • Founders want to avoid raising equity for a temporary timing gap

In these cases, this approach brings cash availability into line with how the project runs, removing the need to delay or dilute early-stage delivery decisions. For businesses weighing how to move forward, reviewing grant eligibility or funding structures early can help confirm whether advance funding is appropriate before delivery commitments are made.

How does grant advance funding support earlier project starts?

Earlier access to capital directly shapes how teams deliver grant-funded projects in practice.

With the right advance funding in place, businesses can protect delivery momentum when project timelines are already fixed:

  • Recruit the right technical talent at the outset
  • Secure suppliers and partners without compromise
  • Maintain planned R&D momentum
  • Keep delivery aligned with commercial objectives

Teams adapt funding to the project, which avoids reshaping scope or sequencing around short-term cash constraints. Teams see clearer execution, fewer workarounds, and more disciplined use of the grant award.

How does grant advance funding affect founder decision-making?

Grant approval often shifts focus for founders and finance leads. The question moves from “Can we secure funding?” to “How do we deliver this project properly?”

Advance funding reduces short-term uncertainty at this stage. It lets leadership teams plan with confidence, commit resources earlier, and stay focused on delivery instead of cash timing.

Innovation projects do not operate in iso They link directly to product roadmaps and customer commitments that shape broader growth plans. Funding that aligns with execution reduces distraction at a stage when leadership attention needs to stay on delivery.

How SPRK approaches grant advance funding

SPRK Capital works with innovation-led UK businesses that rely on R&D and grant-funded project cycles. Its approach to grant advance funding reflects how these projects run in reality.

SPRK focuses on:

  • Understanding grant structures and payment cycles
  • Aligning funding with project timelines

SPRK also works alongside advisers and grant bodies, so delivery continues without unnecessary delay.

Instead of treating grant advances as generic lending, SPRK positions them as part of a wider innovation funding strategy. This allows businesses to move forward without reshaping projects around short-term funding constraints.

What should founders and finance leads consider before using advance funding?

Before using advance funding, founders and finance leads need clarity on timing, repayment, and how funding decisions will affect delivery once the project is underway.

Consider:

  • The expected timing of grant payments
  • How early project costs compare to later stages
  • How repayment fits into cash-flow planning

Clear planning at this stage avoids misalignment later and reduces the risk of funding decisions interrupting delivery. When used with clear planning, this type of funding supports delivery without adding unnecessary complexity.

Moving from grant approval to project delivery

Grant approval marks the start of a new phase rather than the end of funding decisions. For many UK businesses, the challenge lies in moving from approval to action without delay.

Grant advance funding provides a way to start R&D projects when the work needs to begin, not when reimbursement arrives. It can help keep innovation on schedule, protect ownership, and keep teams focused on execution.

If your business has secured a UK innovation grant and faces timing pressure between spend and payment, exploring funding options early can make a measurable difference. Tools that assess eligibility or conversations with specialists can help clarify next steps before project delivery begins.

Are Grants Enough? When SMEs Should Add Non-Dilutive Loans to the Mix

Are Grants Enough? When SMEs Should Add Non-Dilutive Loans to the Mix

/in /by

Many UK SMEs use grants to fund early-stage innovation. Grants protect equity and support technical risk, and they can also demonstrate credibility with customers and investors. However, they can also leave gaps between when SMEs pay staff and suppliers and when grant cash arrives.

Non-dilutive loans give SMEs another way to fund delivery without issuing new shares. When SMEs use these loans alongside grants, they can keep projects moving, maintain teams and reduce delays linked to claim and payment cycles.

In this guide we explain when grants alone may limit an SME’s progress and how to decide whether to add non-dilutive loans to the funding plan.

Are Grants Enough on Their Own for Growing SMEs?

Many SMEs rely on grants because they reduce early financial pressure and help validate technical plans. As companies progress, the limits become clearer. Grant cycles move slowly, payments arrive after claims, and awards often cover only part of project costs. These timing gaps affect hiring and supplier commitments and can slow overall delivery. Even SMEs working with their first significant grant can face these pressures once project costs start to ramp up.

When Should SMEs Combine Grants and Non-Dilutive Loans?

There is no single trigger point. Instead, a few practical signals show when grants alone start to constrain delivery. The scenarios below show where non-dilutive loans can support delivery and growth while grants remain part of the funding plan.

What if you have a grant but lack upfront cash to start delivery?

Many grant schemes pay in arrears and use claim cycles to release funds. In practice, SMEs need to commit to payroll, materials and supplier contracts before they submit the first claim.

If the company does not hold enough working capital to make those commitments, the project can start later than planned or move forward in smaller steps than the original scope assumed.

Here, a non-dilutive loan linked to the grant can bring the timing of payments to staff and suppliers closer to the timing of grant income. For example, grant advance funding or an innovation loan can provide part of the project budget upfront, and the approved grant secures the facility. The SME can then hire the team and place orders according to the technical plan rather than the claims timetable.

What if your R&D programme depends on tax credits that arrive too late?

Some SMEs run ongoing R&D programmes where R&D tax credits form a material part of expected cash inflow. The work continues each month, but tax credit payments arrive after the financial year-end and after HMRC has processed the claim.

If R&D costs rise faster than other income, this timing gap can put pressure on cash balances, even if the underlying claim is strong. Management may respond by slowing hiring, reducing external work or pacing experiments to match available cash rather than the technical opportunity.

In this case, non-dilutive loans that draw on expected R&D tax credits can help. An R&D tax credit loan brings forward part of the anticipated credit so that teams can continue work at the planned pace. When HMRC pays the claim, the company repays the facility from that inflow.

How can you scale beyond what the grant covers?

Grant briefs often define specific work packages and reporting lines. As projects progress, SMEs may identify adjacent features and new use cases that sit outside the written scope, including early commercial pilots.

If management waits for a new grant call to cover these extensions, the company may keep product and market work on hold. Equity funding is one option, but it may not fit the size or timing of the opportunity.

Here, non-dilutive loans linked to innovation work can help fund related development and commercial activity that sits outside the grant brief. Innovation term loans can support this work alongside grant-funded tasks. The SME can move into pilots, customer trials or integration work while it continues to claim under the existing grant.

What if work slows or pauses between grant calls?

Some SMEs build their funding plan around grant competitions, whether they are applying for a first award or managing a sequence of projects. This can work in the early stages but may lead to periods where teams slow down or pause work while they wait for competition results or new calls to open.

Repeated pauses in work can affect staff retention, delivery quality and customer confidence. They may also make it harder to plan longer-term work because each new phase depends on a separate grant decision.

Non-dilutive loans can reduce these delays. Where a company has a history of grant success or regular R&D tax credit claims, facilities such as grant advance funding or R&D tax credit loans can provide a more continuous source of project funding. The SME can then plan programmes over a longer horizon, using grants as part of the overall funding plan rather than as the sole source of external support.

How Does SPRK Support SMEs Using Grants and Non-Dilutive Loans?

SPRK works with UK SMEs that carry out innovation and rely on R&D tax credits or grants as part of their funding. SPRK designs its facilities to align cash inflows from these schemes with the timing of project costs.

SMEs can combine these non-dilutive loans with existing grants to build a funding plan that supports delivery and reduces timing gaps while preserving ownership.

Combine Grants and Non-Dilutive Loans for Timing and Scale

Grants remain a valuable part of funding for SME innovation. They help companies take technical risk and demonstrate quality without affecting equity. However, grant cycles and payment schedules do not always match the pace of project delivery.

Non-dilutive loans give SMEs another way to fund work that depends on R&D tax credits or grants, or to extend programmes beyond a specific brief. By reviewing how much of the funding plan relies on these schemes and where timing gaps appear, management teams can decide when to include non-dilutive loans in the funding plan.

If you want to discuss how non-dilutive loans such as R&D tax credit loans, grant advance funding or innovation term loans could support your projects, you can speak with the team via SPRK’s contact page.

This article provides general information only and does not constitute financial, legal or tax advice.

Your Grant Is Approved. Now What? Managing the Cash Gap After Innovate UK Awards

Your Grant Is Approved. Now What? Managing the Cash Gap After Innovate UK Awards

/in , /by

Winning R&D grants changes your delivery plan, not the timing of cash. Innovate UK usually pays in arrears against eligible, evidenced costs. Fast‑growing teams still face payroll, upfront supplier payments and booked lab time before claims clear. This guide sets out what typically happens after an award and how to keep delivery aligned. It does not provide financial advice.

How do Innovate UK R&D grants pay out?

Most R&D grants pay after you incur and pay eligible costs, often on a quarterly cycle. In practice, you submit a claim that reconciles paid invoices, timesheets for eligible staff, brief progress notes and any outputs required by the offer letter. Each competition sets claim windows. Innovate UK can query or hold a claim until evidence is complete, which can move the cash date. Complete project set‑up before delivery. If set‑up slips, the first claim window moves, and early cash pressure rises.

When you consider start dates and eligibility, wait for the formal go‑live confirmation before starting delivery. Innovate UK usually treats costs before the confirmed start date as ineligible, which can force first‑claim rework.

Because Innovate UK pays only on incurred and paid costs, keep invoices, proof of payment and timesheets aligned to the eligible cost categories in your annexes. Clean records shorten review time and reduce queries.

Some Innovate UK R&D grants pay on milestone acceptance rather than calendar quarters. Cash still lands in arrears against eligible, defrayed costs, so align your internal dates to the scheme’s payment schedule.

To see current Innovate UK competitions, explore our open innovation programmes.

Who signs off your claim before Innovate UK pays?

Your Monitoring Officer reviews costs and progress before authorising R&D grants claims; clear records speed approvals. Prepare claims in your project portal, check them against the offer letter and annexes, then review them with your Monitoring Officer. Clean documentation, consistent timesheets and proof of payment reduce queries and shorten the payment timeline. Even with clear documentation, payment lands after costs; this is where the cash‑flow gap appears.

Where does the cash‑flow gap appear after an Innovate UK award?

Costs often fall before claims pay. Typical pressure points are payroll, upfront supplier payments, booked lab time and scheduled pilot trials.

The pressure points are payroll between sprints, upfront supplier payments and minimum order quantities, booked lab or certification time, and scheduled pilot trials with partners. These dates rarely move; miss them and acceptance can slip into the next quarter, which pushes revenue recognition and partner timelines.

Keep teams in place, secure components on time and protect facility bookings to keep the plan on track. Let dates drift and the roadmap will drift with them.

If timings or scope must change, raise a Project Change Request early. Innovate UK does not accept pre‑start amendments, and extensions late in a project are rarely approved. Submitting changes within project dates and with clear justification reduces disruption.

What is grant advance funding and when does it help?

Grant Advance Funding provides early access to a portion of awarded R&D grants, aligned to dated costs, and settles when claims pay. It helps when supplier windows are tight, lab schedules are locked or hiring depends on hitting milestones. You can draw up to 80% of the quarter or milestone at the start of the period. We map drawdowns to your dated plan and reconcile when the claim pays. Because advances are non‑dilutive, you retain ownership while meeting deliverables and evidence requirements on time.

What causes claim queries or delays, and how do you avoid them?

Typical issues on R&D grants include pre‑start costs, missing proof of payment, timesheets not mapped to eligible categories, late submissions and budget changes without a PCR. Use a short pre‑submission check against the annexes, claim windows and PCR rules to prevent rework and keep payment dates predictable.

If you need a quick sense check, use our grant eligibility checker.

Why are grants paid in arrears, and where does a grant advance fit?

UK public R&D grants operate on a cost‑recovery model. Payment follows evidence and claim review, which protects the fund but can leave delivery out of step with cash. Where evidence cycles delay liquidity, a grant advance can align funds to dated costs and reconcile when the claim pays.

How does SPRK structure grant advance funding?

We size the advance against your award letter and milestone schedule and align it to the relevant quarter or milestone. Have a project plan/Gantt with dates and a 13‑week cash‑flow ready so timing is clear. We agree the advance for each period and fund within 24–48 hours of signing; repayment follows your grant receipt. Interest is added to the principal and there are no interest payments during the term; you settle interest when the claim pays. Once the grant payment lands, you settle the advance within 48 hours. The minimum term is three months.

We take a first‑ranking fixed and floating debenture; if an existing charge is in place, we discuss options case by case. There are not early‑repayment fees. Once information is complete, we decide quickly and confirm drawdowns in writing against your plan. Grant advances can run alongside other tools when the use of funds is clear, and the cash profile supports repayment. For adjacent options, see Innovation Term Loans or R&D Tax Credit Loans.

How do grant advances differ from R&D tax credit loans?

Both bridge pre‑receipt costs, but repayment sources and use cases differ: a grant claim versus an HMRC R&D credit.

Both options address pre‑receipt costs, but they rely on different sources of repayment and fit different use cases:

  • Source of repayment: grant claim versus HMRC R&D credit.
  • Timing: both bridge dated costs ahead of cash‑in; mechanics differ.
  • Use case fit: grant advances for project delivery; tax‑credit loans for the incentive timing.

Grant advances settle from your R&D grant claim. R&D tax credit loans settle from your HMRC R&D credit and can provide up to 80% of the expected credit.

Why choose SPRK for an R&D grant advance?

Institutional capacity, innovation‑focused decisioning and clear scheduling aligned to your dates.

  • Institutional capacity: backed by a £20 million British Business Investments facility, supporting R&D grants drawdowns.
  • Innovation focus: decisioning mapped to R&D plans and milestones.
  • Clarity and speed: transparent terms and drawdowns confirmed to your dates.

Keep delivery moving between award and claim payment

If you have been awarded an Innovate UK R&D grant and need to keep delivery aligned to your plan, Grant Advance Funding can help. Tell us your next acceptance date and the costs between now and then. We will outline a non‑dilutive grant advance that fits those dates. Contact the team.

 

Improve Cash Flow with Grant Advance Funding

Improve Cash Flow with Grant Advance Funding

/in , /by

Grant advance funding helps you fund supplier deposits, payroll, and milestone work on the dates you planned. Use claim reimbursements to step the balance down while you keep equity.

Before you pick a facility, run a 10‑minute audit: list the next two claim windows, the supplier ship dates, and payroll Fridays. If the dates don’t line up, grant advance funding turns the plan into a calendar you can actually run. That discipline improves cash predictability while you scale, without selling more of the company.

Turn your grant plan into a cash calendar

Grants pay after defrayal and evidence, which means your bank funds the work first. The gap sits between purchase orders, payroll, and the claim window, and that’s where dates slip. Grant advance funding maps cash to your milestone plan: you draw for near-term work, deliver and capture evidence, submit the claim, and use reimbursement to bring the balance down. This helps delivery stay on schedule, suppliers stay engaged, and you keep your cap table unchanged.

If a date moves, shift the later draw instead of stretching cash across two milestones. Lock the plan to real artefacts: POs, supplier pro formas, payroll dates, and claim windows. Put them on one calendar and pin draw dates to those events. For a facility built around this calendar, see our grant advances. Not sure on fit? Try the grant eligibility checker.

When should we use a grant advance?

Grant advance funding is for work that starts before reimbursement when you can evidence defrayal on schedule.

  • Supplier deposits for hardware, tooling, or labs
  • Payroll for specialist hires that need to start before claims land
  • Milestone spend where defrayal occurs ahead of submission windows

When not to use it: skip it if scope is unclear, evidence is missing, or milestones keep slipping.

How does grant advance funding improve cash flow?

Grant advance funding maps cash to milestones: draw → defray → claim → reduce so payroll and suppliers stay on date.

Work the loop in order: draw for the milestone, pay and capture evidence, submit the claim, then use the reimbursement to bring the balance down. That way, claim payments step the balance down without squeezing minimum cash. A weekly forecast and evidence run keeps suppliers confident, can improve terms, and helps payroll land on time. For multi‑year predictability, consider Innovation Term Loans.

Want a draw plan you can model this afternoon?

Share your award letter and milestone calendar. We can propose an indicative draw plan and show how repayments step down after claims, subject to diligence and credit approval. Contact the SPRK team.

What will a lender ask for?

Approvals move faster when you bring a clean pack that reconciles invoices ↔ bank proof ↔ deliverables for the next claim window.

Bring a clean, consistent pack so approvals move quickly:

  • Grant letter or award and any amendments
  • Milestone plan with dates, deliverables, owners, and amounts
  • Cost summaries that match the grant categories
  • Eligibility and status confirmed
  • Evidence plan for invoices, bank proof of defrayal, and deliverables
  • Management accounts and a 12‑month forecast
  • Bank statements (3–6 months) and AR/AP ageing

That reduces diligence back‑and‑forth and can bring the first draw forward.

Pro tip: maintain an evidence matrix mapping each cost line to the invoice, bank proof, and milestone output. Each cost line should have an invoice number, a bank transaction ID, and a deliverable link. If anything is missing, leave the line out until it’s complete.

How do repayments work with claims?

Repayments follow a fixed schedule. When a claim reimbursement arrives, prepay to reduce the balance and lower future repayments. If a reimbursement lands at 50% or more of the drawn amount, prepay that week to step repayments down. Confirm early‑repay terms and how claim funds flow so the process stays straightforward. Price this off the low case so the step‑down still clears in the trough month.

Micro‑math example: Draw £250k for a supplier deposit on Milestone 2. If the claim pays 60% about six weeks after submission, a £150k reimbursement lets you prepay so the next repayment steps down. If the claim slips by two weeks, the staged draw still protects payroll.

How big should the advance be?

Grant advance funding should be sized to the next 1–2 milestones and the low case on timing; stage draws if lead times stretch.

Size the facility to the next one or two milestones and to the low case on timing. Add buffer for payment lags and supplier lead‑time changes. If lead time exceeds eight weeks, stage the deposit draw and shift the balance to the week the parts ship. Confirm that repayments fit your trough month even if a claim moves right. Hold two months of burn above minimum cash; if you can’t, cut the facility or shorten availability. The buffer absorbs slips in lead‑times or claim dates.

Note: Some programmes (for example, Horizon Europe) provide pre‑financing; size any advance with that tranche in mind. If your plan also includes an HMRC R&D claim, read R&D tax credit advances.

Decision rule: stage the facility across availability windows that match milestone dates. If a date slips, push the later draw so minimum cash stays above your buffer.

What costs and risks should we plan for?

Price on all‑in cost to maturity and plan buffers for claim and supplier timing.

Costs: interest, an arrangement fee, legal and diligence costs, and any maturity or prepayment terms. Compare on all‑in cost to maturity, not the headline rate. Grant advance funding benefits from transparent pricing and simple terms.

Risks: milestone slips, evidence gaps, and supplier delays. Mitigate with staged draws, an evidence matrix, and a weekly owner on claims. Keep a buffer so one slow month doesn’t create pressure. Freeze scope two weeks before each claim window and maintain a claim calendar. Reconcile the bank feed to your evidence weekly and leave out any line you can’t evidence. Ensure the claim workbook and the evidence folder match line for line.

Can we combine grant advances with other non‑dilutive tools?

Yes. Grant advance funding can sit alongside other non‑dilutive tools if cash flows do not compete and security is clear. Common pairings:

Assessing a grant path? Use our grant eligibility checker to sense‑check eligibility.

What will improve approval speed?

Grant advance funding moves faster when you set clear scope and keep evidence clean. Align purchase orders to milestone lines, reconcile bank payments to invoices, and keep the evidence folder current. Fix cross‑project issues first; Innovate UK can pause payment if another project is out of compliance. Share the milestone calendar with us and we’ll stage draws against it.

Two typical scenarios we see in practice: A life‑sciences team missed a claim window by three days; we staged the next draw, payroll cleared, and the claim calendar moved a week earlier. A robotics supplier slipped on lead time; we pushed the second draw, resequenced the evidence, and minimum cash stayed above buffer.

Fund milestones on schedule and keep ownership

Grant advance funding works when it follows your programme. SPRK maps draws to milestone dates, ties evidence to spend, and keeps documentation simple so your team can focus on delivery. We size to the low case and plan buffers for payment lags, which helps protect payroll and supplier commitments without giving up equity. If a milestone moves, we adjust the draw schedule and keep the claim loop clean.

If you want a lender to meet you at the operational level of dates, amounts, evidence, and repayments, contact the SPRK team. Email the board pack and milestone plan today. We’ll return two facility sizes, the first amortisation month, and a draw schedule pinned to your claim calendar so you can decide quickly.

 

Levelling the Playing Field for Innovation: How Innovation Grants and CDFIs Support Underserved Entrepreneurs

Levelling the Playing Field for Innovation: How Innovation Grants and CDFIs Support Underserved Entrepreneurs

/in /by

Across the UK, groundbreaking ideas emerge from every sector and region, from medtech in Manchester to clean energy in Cornwall. Yet, access to the capital needed to turn those ideas into market-ready products isn’t equal. Venture capital is heavily concentrated in London and the South East, while traditional bank loans can be hard to secure for early-stage innovators without collateral or trading history.

For entrepreneurs in underserved areas or from underrepresented groups, this gap between potential and progress can slow the journey from concept to commercialisation. Innovation grants can bridge that gap but often need to be paired with other finance tools to fully fund a project. This is where Community Development Finance Institutions (CDFIs) provide essential support.

When Can Innovation Grants Become a Turning Point for Your Business?

Innovation grants are non-repayable funds awarded to businesses developing products, services, or processes that deliver measurable advances. In the UK, these are often provided by Innovate UK, regional growth funds, and other public bodies. If you’re exploring innovation grant funding UK options, start with Innovate UK competitions and your regional growth hub’s eligibility and timetable pages.

Key characteristics include:

  • Competitive application process with awards granted to proposals showing clear technical innovation and commercial potential.
  • Upfront or staged payments linked to milestones such as prototype delivery or trial completion.
  • Funding ring-fenced for project-specific costs like specialist hires, testing, or equipment.

Unlike R&D tax credits, which are claimed after expenditure, innovation grants provide funds during the project. This enables investment in materials, staff, or testing before revenue arrives. Grants can be particularly transformative for sectors with high upfront costs, such as biotech or advanced manufacturing, where early funding accelerates research and reduces the risk of missed opportunities.

Examples include a medtech team developing new diagnostic devices, a clean tech company creating emission-reduction systems, and an agri-tech business improving crop yields through sustainable methods. In each case, early-stage funding allowed them to progress faster and secure follow-on investment. For founders, the difference can mean reaching commercialisation a year earlier or attracting investor confidence at a critical point.

What Role Do CDFIs Play in Supporting Innovation?

CDFIs are mission-led lenders providing loans to businesses and social enterprises underserved by mainstream finance. They assess business potential and community impact rather than focusing solely on collateral or credit score.

The British Business Bank highlights that CDFIs excel at supporting businesses in rural or economically deprived areas, funding entrepreneurs from underrepresented backgrounds, and providing smaller, flexible loans that banks may decline. They often bring sector-specific understanding and can offer mentorship alongside finance.

How Do Innovation Grants and CDFIs Work Together to Fund Startups in the UK?

Winning an innovation grant is often just one step in the funding journey. Some competitions require match funding, while others release funds in stages, creating potential cash flow gaps.

Ways CDFIs complement grants include:

  1. Match funding: covering required business contributions.
  2. Bridging finance: short-term loans until the next grant drawdown.
  3. Complementary capital: financing operational needs beyond the grant scope.

For example, a clean-tech startup in Cornwall wins a grant for a low-energy water filtration system. The grant covers prototype development, but the business needs to hire engineers and secure a larger workshop. A local CDFI steps in with a flexible loan, ensuring the project stays on schedule.

In Manchester, a medtech company used an Innovate UK feasibility grant to validate a digital diagnostics workflow and a local CDFI to match-fund lab equipment and regulatory support, keeping trials on track.

Can Innovation Grants and CDFIs Really Close the UK’s Funding Gap?

Innovation grants and CDFIs help address this imbalance by funding underserved regions, supporting overlooked sectors, and creating local economic impact through jobs and supply chains.

To maximise the benefit, founders should look at aligning their funding approach early identifying potential grants, preparing competitive applications, and speaking to CDFIs before projects start. Proactive planning can ensure there are no delays between milestones and funding availability.

SPRK Capital’s Role in Supporting Underserved Innovators

SPRK Capital complements both innovation grants and CDFIs by providing Grant Advance Funding enabling founders to access awarded grant money before it arrives.

For underserved innovators, this means faster starts, reduced cash flow pressure, and greater certainty when matching hiring, procurement, and production schedules to project needs.

SPRK’s ability to deliver is strengthened by a £20 million facility from British Business Investments, making us the first innovation specialist lender to receive such backing. This ensures we can fund projects at scale quickly and on founder-friendly terms.

Practical Steps to Access Innovation Grants and CDFI Funding

  1. Identify relevant grants via Innovate UK, regional growth funds, and sector-specific competitions; the fastest route if you’re asking how to apply for innovation grants in the UK.
  2. Prepare a robust application with technical detail, market opportunity, and a commercialisation plan.
  3. Engage with CDFIs early to discuss potential match or bridging needs.
  4. Plan for grant drawdown timing.
  5. Consider a grant advance from SPRK Capital.
  6. Build relationships with regional innovation networks to uncover opportunities not widely advertised.
  7. Keep accurate project documentation to speed up compliance checks and funding release.

Why This Matters for Founders

Innovation should be judged on merit and impact, not postcode or immediate cash reserves. Combining innovation grants, CDFI loans, and SPRK’s grant advance funding ensures great ideas have the financial support to reach the market. For founders in underserved areas, this approach not only opens the door to growth capital but also creates a pathway to long-term sustainability and investor readiness.

Move Your Innovation Forward

If you’ve secured an innovation grant but face funding gaps, contact SPRK Capital today. Our team will help you access your awarded funds early, align cash flow to project milestones, and keep your innovation moving anywhere in the UK.

 

innovation grants

How are Innovation Grants Affected by the “Budget for Growth”

/in , /by

Innovation grants have long been a cornerstone in nurturing the UK’s burgeoning tech and science sectors. The Spring 2023 Budget, termed “Budget for Growth” by Chancellor Jeremy Hunt, is poised to significantly alter the grant process. This piece delves into what this budget means for innovation grants and, by extension, for innovators and entrepreneurs across the United Kingdom.

Context of the Budget for Growth

This budget announced several key measures affecting the UK’s tech landscape. Here is the summary:

  • The Establishment of 12 Investment Zones
    Each is to be funded with £80 million over five years. These zones, strategically located around university tech hubs in England, Scotland, Wales, and Northern Ireland, aim to create synergies between academia and industry, fostering an environment conducive to technological breakthroughs and entrepreneurial ventures.
  • Plan for Quantum
    Committing to make the UK a world-leading quantum-enabled economy by 2033. This ambitious plan is underpinned by a £2.5 billion research and innovation programme, reflecting a significant investment in future technologies.
  • Energy Sustainability
    The budget allocates £20 billion over the next two decades for low-carbon energy projects, emphasising carbon capture and storage.
  • Defence Spending
    An £11 billion allocation, which includes a focus on innovation, underlining the government’s commitment to integrating cutting-edge technology in national defence.
  • Supercomputing Facility
    The budget significantly bolsters the UK’s tech ambitions with a £900 million investment to establish the nation as a leader in AI research. This commitment is further highlighted by the introduction of the Manchester Prize, offering a £1 million annual award for pioneering British AI research.
  • R&D Tax Relief Policies
    Designed to incentivise innovation, particularly benefiting small and medium-sized businesses focusing heavily on R&D, thus encouraging deeper engagement in innovative activities across various sectors.

Impact on Innovation Grants

The revised budget framework heralds significant changes for the near future of innovation grants in the UK. The targeted increase in funding and focus on sectors like

  • Quantum Computing, AI, and Low-Carbon Technologies
    Suggesting a strategic realignment of grant opportunities, this shift implies that grants will likely be more concentrated in these cutting-edge fields, presenting increased opportunities for innovators specialising in these areas. Consequently, innovators must closely align their projects with the government’s strategic priorities, emphasising the importance of staying attuned to emerging trends and policy directions.
  • Establishing Investment Zones
    This marks a pivotal shift towards a regionally focused approach to grant allocation. Centred around tech hubs and universities, these zones are set to become hotbeds of innovation, potentially offering a more supportive and resource-rich environment for startups and tech companies. This regional focus could lead to a more equitable distribution of resources and opportunities across the UK, thereby nurturing a more diverse and vibrant innovation ecosystem.
  • Enhanced R&D Tax Relief for SME
    Tailored to encourage more profound and consistent investment in R&D among small and medium-sized enterprises (SMEs). By allowing these businesses to claim greater relief on their R&D spending, the government is effectively lowering the financial barriers to innovation. This move is expected to stimulate a more dynamic and varied innovation landscape, with SMEs playing a more prominent role in driving technological advancements.

Adaptation Strategies for Innovators

As funding adapts to such rapid developments, innovators must be tactical in their approach. Prioritising research and development in areas highlighted by this blog is a step in the right direction. This focus bolsters the likelihood of grant success and ensures that innovations are relevant to current national and market trends.
Moreover, seeking collaborative opportunities with academic institutions and other organisations within the newly established investment zones is a sensible strategy. These partnerships, potentially involving joint research projects or shared use of resources, can offer valuable support and insights. By engaging with these networks, innovators can access a wider range of expertise and resources, aligning their projects more closely with the strategic direction set by the new budget, which could prove beneficial in navigating the evolving innovation landscape in the UK.

Preparing for the Future of Innovation Grants

The “Budget for Growth” marks a pivotal moment for innovation grants in the UK, promising new opportunities but also pivotal challenges. This necessitates a strategic realignment for innovators. As we step into this new era, it’s vital for those in the tech and science sectors to engage with these changes.

Our expertise in grant advance funding and R&D tax credit loans – in addition to the innovation space as a whole – positions us uniquely to support your ventures as we move forward. Get in touch with us, and we can talk about how you can effectively leverage the financial resources needed.